Vanboven Melvin DO - OK Osage, Tulsa 74127

Vanboven Melvin DO entered the industry of Pathological Laboratories in 1987 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Pathological Laboratories. For further clarification, the SIC classifies this business under the code 8071 and described it as a Pathological Laboratories. The business provides service to the B2C market.

To acquire more information, please contact Melvin Vanboven by calling (918) 582-0001 during business hours. You can also write to the business’ Single Location at 802 South Jackson Avenue # 135, Tulsa, Oklahoma OK 74127. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Vanboven Melvin DO
Representative: Melvin Vanboven
Place of Business: 802 South Jackson Avenue # 135, Tulsa, OK 74127
Contact Number: (918) 582-0001
Type of Service: Pathological Laboratories
SIC Number: 8071
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1987
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Vanboven Melvin DO is a company operating from Osage, Oklahoma providing professional Pathological Laboratories and relevant B2C variables. It was founded in 1987 and registered with the SIC code 8071 as Pathological Laboratories, and with the NAICS code 6211110 as Pathological Laboratories.

With a current employee count of 1 to 4, Vanboven Melvin DO has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Melvin Vanboven at (918) 582-0001 for related queries, or to locate its Single Location using the coordinates 36.146923,-95.999429.

The Single Location can also be found at the street address 802 South Jackson Avenue # 135 in Tulsa, Oklahoma 74127 and can be engaged online through the company website at , the company Twitter , and Facebook page .